Table 5 Univariate logistic regression analysis for predictors of response to induction therapy (D28)
From: Reductive regulation of BECN1 gene in adult Egyptian patients with do novo AML
Parameter | P value | Odds ratio (OR) | 95% C.I. for OR | |
|---|---|---|---|---|
Lower | Upper | |||
Age ≤ 51 years | 0.000 | 56.000 | 6.259 | 501.026 |
TLC ≤ 25.9 × 103/ul | 0.000 | 50.375 | 8.189 | 309.892 |
PB blasts > 35% | 0.019 | 0.190 | 0.048 | 0.763 |
Normal Karyotype | 0.010 | 6.781 | 1.585 | 29.016 |
CD34 + | 0.003 | 0.125 | 0.032 | 0.485 |
CD117+ | 0.005 | 0.148 | 0.039 | 0.561 |
HLADR+ | 0.021 | 0.121 | 0.020 | 0.723 |
Reduced BECN1expression | 0.000 | 0.065 | 0.014 | 0.288 |